MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Multimodal Graph Theory Analysis Identifies Reward Network in Prediction of Motor Response to Deep Brain Stimulation

    J. Muller, L. Li, C. Matias, M. Alizadeh, J. Miao, S. Thalheimer, V. Romo, F. Mohamed, C. Wu (Philadelphia, PA, USA)

    Objective: Identify structural and functional networks that may be used to predict motor improvement after deep brain stimulation (DBS), supporting the existence of an underlying…
  • 2019 International Congress

    Dopaminergic imaging in patients with basal ganglia calcification presenting with parkinsonism

    A. Planas-Ballvé, N. Caballol, M. Balagué, E. Peral, L. Cano, X. Cardona, L. Vila, A. ávila (Sant Joan Despí, Spain)

    Objective: To evaluate the integrity of the nigro-striatal system with single photon emission computed tomography imaging with dopamine transporter (DaTscan) in patients with basal ganglia…
  • 2019 International Congress

    Ponto-cortical aberrations:Neural correlations for Hypomimia in PD

    P. Singru, V. Vadiyala, E. Ganesh, V. Vinodhanand (Georgetown, Guyana)

    Objective: We team neuron, focused on analyzing progressive degeneration of neural structural connectivity of the tract from Brodmann area 4, part precentral gyrus to facial motor…
  • 2019 International Congress

    Evaluation of Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s Disease: An in vivo [11C]BU99008 PET study

    H. Wilson, G. Dervenoulas, G. Pagano, R. Tyacke, J. Myers, R. Gunn, E. Rabiner, D. Nutt, M. Politis (London, United Kingdom)

    Objective: We aimed to evaluate the role of astroglia activation in Parkinson's disease (PD) using [11C]BU99008 PET, a novel radioligand with high specificity and selectivity…
  • 2019 International Congress

    Comparison of Current DBS Platforms in the United States

    L. Surillo, U. Yazdani, S. Chitnis (Dallas, TX, USA)

    Objective: To compare and contrast the currently available deep brain stimulation (DBS) platforms in the United States, their technical features, capabilities and practicality of usage.…
  • 2019 International Congress

    Dielectric Properties of a Blood Plasma Predict Motor Deficits in a 6-Hydroxydopamine-Induced Rat Model of Parkinson’s Disease

    E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)

    Objective: This study presents a novel method of predicting the behavioral pattern in male Sprague-Dawley rats with motor deficits impairment, based on the measurement of…
  • 2019 International Congress

    Predicting the functional impact on the performance of daily activities in people with PD: a novel approach based on objective measures obtained by inertial sensors

    K. Lebel, C. Duval, E. Goubault, S. Bogard, P. Blanchet (Montreal, QC, Canada)

    Objective: To predict global motor disabilities using symptomatology assessed with inertial sensors, medication regimen, and cognitive deficits through: (1) a clustering method on performance metrics…
  • 2019 International Congress

    Substantia Nigra (SN) Hyperechogenicity as seen in Transcranial Sonography (TCS) is a reliable disease progression marker from Stage I to Stage II in Early Onset Parkinson’s Disease (EOPD)

    S. Ravi, V. Shivkumar, D. Dang, T. Gilmour, A. Espay, J. Wang, T. Subramanian, K. Venkiteswaran (Hershey, PA, USA)

    Objective: To test the hypothesis that SN hyperechogenicity seen in transcranial sonography (TCS) can be used as a reliable disease progression marker from stage I…
  • 2019 International Congress

    Speech impairment as a marker of clinical changes in premanifest Huntington’s disease

    J. Chan, Y. Lie, J. Stout, A. Vogel (Melbourne, Australia)

    Objective: Speech disturbances have been described in premanifest Huntington’s Disease (HD). Yet a recent systematic review and meta-analysis highlighted disagreement in the literature regarding the…
  • 2019 International Congress

    Assessment of Gait in Huntington’s disease patients using EncephaLog smartphone’s application

    NI. Inbar, N. Omer, A. Bar David, N. Geva, I. Dabakarov, L. Barsky, Z. Yekutieli, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: Huntington’s disease (HD) patients cope with unique gait disturbances. Proper evaluation of gait in these patients is highly needed. Dyskinesia may negatively affect validity…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 217
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley